- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01818609
Study of Inactivity on Metabolism of Elderly Muscles
February 21, 2020 updated by: McMaster University
Influence of Reduce Daily Step Count on Muscle Protein Metabolism in Older Persons
Skeletal muscle mass declines with inactivity (casting is a good example) and increases with activity (such as weightlifting).
Whether muscle mass increases or decreases, is determined by whether more new proteins within muscle are made than are broken down.
The investigators know that feeding protein increases the synthesis of new proteins but that the response of older muscles to protein feeding is blunted compared with the young.
This resistance of the elderly to muscle building stimuli may be the primary reason that muscle mass is lost in aging.
The investigators also know that periods of muscle disuse such as casting result in a person's muscle shrinking due, the investigators believe, to a lower rate of synthesis of new muscle proteins.
Age-related muscle loss begins around 50 years old and proceeds at approximately 1% for every year after.
Elderly persons would likely fare well with advancing age if their muscle loss were simply linear; however, a rate of muscle loss of 1% annually is a 'population view' and does not represent what occurs during short periods of muscle disuse (i.e. during hospitalization or illness), which occur with increasing frequency in elderly persons.
During periods of disuse, the resistance of elderly muscles to protein nutrition may be worsened.
The investigators will measure how quickly new proteins are made at rest and after protein feeding in elderly men, before and after a 14 day period of reduced activity brought on by having people reduce their daily step count.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4K1
- McMaster University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or Female
- Aged 60 to 80 years old
- Non-smoker Generally healthy and can tolerate the resistance exercise and protein drink
Exclusion Criteria:
- Allergies to whey protein
- Health problems such as: heart disease, rheumatoid arthritis of the knee joint, diabetes, poor lung function, uncontrolled hypertension, or any health conditions that might put participants at risks for this study
- Failed an exercise stress test
- Taking metformin and/or other medications for the control of blood glucose even though one might not be classified as diabetic
- Taking prescribed blood thinners such as warfarin and heparin but excluding aspirin
- Taking medications for lung and kidney conditions but excluding medication for asthma that is under control
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Step Reduction
Step reduction:
|
taking less than 1500 steps/d
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fractional synthetic rate (FSR) of myofibrillar muscle protein
Time Frame: over 5h
|
rate of making new muscle proteins
|
over 5h
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood amino acid concentrations
Time Frame: over 5h
|
concentration of amino acids in blood
|
over 5h
|
Intramuscular signalling protein status
Time Frame: over 5h
|
phosphorylation of key signalling proteins
|
over 5h
|
Insulin sensitivity via blood sampling
Time Frame: over 5h
|
measure of insulin concentration
|
over 5h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
July 19, 2011
First Submitted That Met QC Criteria
March 21, 2013
First Posted (Estimate)
March 26, 2013
Study Record Updates
Last Update Posted (Actual)
February 25, 2020
Last Update Submitted That Met QC Criteria
February 21, 2020
Last Verified
March 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 267
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcopenia
-
University of Texas at AustinNot yet recruitingExercise Training and SarcopeniaUnited States
-
Centre Hospitalier Universitaire DijonCompleted
-
Creighton UniversityUniversity of NebraskaRecruiting
-
University Hospital, CaenCompleted
-
University of NottinghamUniversity of OxfordRecruitingMuscle Atrophy | Age-Related SarcopeniaUnited Kingdom
-
Tufts UniversityNational Institute on Aging (NIA)CompletedMuscle Loss | Age-Related SarcopeniaUnited States
-
China Medical University HospitalCompleted
-
King's College LondonCo-sponsor: Guy's and St Thomas' NHS Foundation TrustCompletedFrailty | Sarcopenia | Age-Related SarcopeniaUnited Kingdom
-
Norwegian School of Sport SciencesOslo University HospitalNot yet recruitingHealthy Aging | Testosterone Deficiency | Age-Related Sarcopenia
-
Ningbo Medical Center Lihuili HospitalCompletedHemodialysis Patients With SarcopeniaChina
Clinical Trials on Step reduction
-
University of UtahUniversity of Utah Center for Clinical and Translational Science (CCTS)CompletedAging | Skeletal Muscle | Vascular EndotheliumUnited States
-
McMaster UniversityCompletedOlder Adults | Muscle Protein Synthetic Response to Protein | Reduced Physical ActivityCanada
-
University of JyvaskylaUniversity of Eastern FinlandCompletedBody Weight Changes | Walking, Difficulty | Muscle DegenerationFinland
-
University of BathCompletedMuscular AtrophyUnited Kingdom
-
McMaster UniversityCanadian Diabetes AssociationCompleted
-
Royal Brompton & Harefield NHS Foundation TrustUnknownMuscle Atrophy | Chronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of NottinghamCompleted
-
University of TorontoRecruitingSarcopenia | Aging | Sedentary Behavior | Amino Acids | Dietary ProteinCanada
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Reuth Rehabilitation HospitalCompletedAcquired Brain InjuryIsrael